GCH Capital Partners Inc.

June 05, 2008 20:28 ET

GCH Capital Partners Inc. Shareholders Vote in Favour of Management

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 5, 2008) - GCH CAPITAL PARTNERS INC. (TSX VENTURE:GCW.P) (the "Company"), a capital pool company incorporated under the laws of British Columbia, is pleased to announce that at the Company's Annual General and Special Meeting held May 30, 2008, shareholders adopted all of the resolutions presented by management, reappointing Davidson & Company LLP as auditor, re-electing Kenneth A. Cawkell, Gerri Greenham, and Wendy Ripley as directors and electing Richard Wagner, Mark Long and Philip Ranck as new appointees to the board. The shareholders approved the Company's existing stock option plan, amendments to the Company's Articles, and the name change of the Company to Solarvest BioEnergy Inc. The shareholders also approved the Qualifying Transaction, which will result in the Company acquiring the worldwide rights to the Hydrogen Technology, as disclosed in the Company's information circular and described in the Company's press release dated March 31, 2008. Completion of the Qualifying Transaction and the Company's change of name remain subject to approval from the TSX Venture Exchange.

The Company welcomes Richard Wagner, Philip Ranck and Mark Long to the Board of Directors and believes that their experience will be invaluable in achieving the Company's goals.

The Company's management would also like to thank its shareholders for their support and looks forward to the continued development of the Company.

The statements made in this Press Release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and projections.

The TSX Venture Exchange has neither approved nor disapproved the contents of this Press Release.

Contact Information

  • GCH Capital Partners Inc.
    Kenneth A. Cawkell
    CEO, CFO and Secretary
    (604) 684-3323
    (604) 684-3350 (FAX)